This company
The company's name, 4 additional officers and directors
Every relationship, signal and contact on this record, with the source on each.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
What matters now
- 1 investornamed
1 investor on record.
The investors already on the cap table shape who leads the next round.
- 5 directorsboard
5 directors on record from Form D filings and board-seat attributions.
The board is who decides on the next round and on a sale.
Facts
Financing history
- Dec 19, 2017Form D equity offering · $5.0M (form d sold) · 5 investorsMPM Bioimpact via Luke Basil EvninFact Form D
- Dec 2, 2014Form D equity offering · $30.0M (form d sold) · 6 investorsMPM Bioimpact via Luke Basil EvninFact Form D
Who would invest
How comparable investors are foundComparable investors backed two or more of the companies this company’s own investors also back. Broader fit co-invested two or more times with them and dated a new company in the last 12 months. Each reason is a fact on record: a shared company, a co-investment count, a dated deal, a stage or round size it has joined. A shared sector alone never puts a firm here. Nothing is a prediction that a firm will invest.Already invested
1 investor on record- MPM Bioimpact form d related, Luke Basil Evnin (strongly supported) Inference sec.gov
- MPM Bioimpact form d related, Luke Basil Evnin (strongly supported) Inference sec.gov
Strong comparable investors
3 firmsFirms that backed two or more of the companies this company's own investors also back.
- NEA: New Enterprise Associates
- Backed 3 companies this company's investors also back
- Co-invested 4 times with 1 of this company's investors
- Has joined rounds of $5M to $15M (16 on record)
- No new company dated in 12 months; latest deal Dec 16, 2025
- Followed on in 41% of its companies
- Lumira Capital
- Backed 2 companies this company's investors also back
- 2 new companies dated in the last 12 months, latest Sep 22, 2026
- 2 funds raising or deploying (newest vintage 2022)
- Cure Ventures Management, LP
- Backed 2 companies this company's investors also back
- No dated deal on record
Broader fit
0 firmsFirms that co-invest repeatedly with this company's investors and dated a new company in the last 12 months.
No other firm co-invests repeatedly with this company's investors on record.
Ownership and outcomes
How these are wordedA company a buyout or growth firm lists on its own site is “listed in the portfolio of”, never “acquired by”. A date prints only when a deal record gives one; otherwise the row says when DFX first saw it.No firm portfolio page lists this company, so no outcome is stated.
Credit relationships
How a loan is matchedA BDC reports its loans by borrower name. A position shows here only when the match passed a precision gate (a hand-labelled sample was 29 of 30 correct); the tier and confidence are printed on each row. Amounts are the lender’s reported position, never a round.People
- Cynthia Seidel-Dugan Executive Officer sec.gov
- Daniel Hicklin Executive Officer/Director sec.gov
- David Cordo Executive Officer sec.gov
- Shunichiro Matsumoto Director Fact
- Phil Gutry Director Fact
Show all 6 officers and directors
- Cynthia Seidel-Dugan Executive Officer sec.gov
- Daniel Hicklin Executive Officer/Director sec.gov
- David Cordo Executive Officer sec.gov
- Shunichiro Matsumoto Director Fact
- Phil Gutry Director Fact
- Arnold Oronsky Director Fact
Timeline
Evidence
Every observation on this company
Relationships across DFX
on 1 other DFX graph
This company is the same institution as 1 record in Private Equity.
The joined record opens with the product, beside every other relationship on this page.
Checking your plan…